Andere Kunden interessierten sich auch für
![Ovarian Cryopreservation and Bone Effects: A New Paradigm]( "Ovarian Cryopreservation and Bone Effects: A New Paradigm")
Ovarian Cryopreservation and Bone Effects: A New Paradigm27,99 €![Clinical Practice Guidelines in Atrial Fibrillation: a systematic review]( "Clinical Practice Guidelines in Atrial Fibrillation: a systematic review")
Clinical Practice Guidelines in Atrial Fibrillation: a systematic review51,99 €![Stem cell biobank]( "Stem cell biobank")
Stem cell biobank51,99 €![Optimal use of sanitary waste incinerators in Africa]( "Optimal use of sanitary waste incinerators in Africa")
Optimal use of sanitary waste incinerators in Africa26,99 €![Guidelines for improving lifestyles and quality of life]( "Guidelines for improving lifestyles and quality of life")
Guidelines for improving lifestyles and quality of life36,99 €![The Frith Prescribing Guidelines for People with Intellectual Disability]( "The Frith Prescribing Guidelines for People with Intellectual Disability")
The Frith Prescribing Guidelines for People with Intellectual Disability82,99 €![Essential guidelines for local therapy of wounds and burns]( "Essential guidelines for local therapy of wounds and burns")
Essential guidelines for local therapy of wounds and burns30,99 €
Erythrocyte components (EC) and platelet concentrates (TC) are in demand for the treatment of patients with anemia and thrombocytopenia, developing against a background of massive blood loss in polytrauma, as well as after chemo- and radiotherapy. At present in the USA 1.5 million TC transfusions are performed annually, and in European countries - 2.9 million. In the Russian Federation about 500 thousand TC are procured annually, at that EC are in greater demand. In 2012 about 2 mln. doses of EC were stocked in the Russian Federation. The deficit was about 1.4 mln doses. The Russian Federation is witnessing the growth of preserved red blood cells harvesting from 43139 doses in 2002 to 48808 doses in 2013.